{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:36:01Z","timestamp":1791776161650,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015640","name":"Huazhong University of Science and Technology Tongji Medical College Tongji Hospital","doi-asserted-by":"publisher","award":["2025B04"],"award-info":[{"award-number":["2025B04"]}],"id":[{"id":"10.13039\/501100015640","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.tranon.2025.102652","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T07:58:05Z","timestamp":1765958285000},"page":"102652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Multi-omics characterization identifies AHCY as a prognostic biomarker driving immunometabolic reprogramming in bladder cancer"],"prefix":"10.1016","volume":"64","author":[{"given":"Qiao","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjue","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baimei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyou","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tranon.2025.102652_bib0001","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin"},{"issue":"19","key":"10.1016\/j.tranon.2025.102652_bib0002","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder Cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.tranon.2025.102652_bib0003","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur. Urol"},{"issue":"12","key":"10.1016\/j.tranon.2025.102652_bib0004","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/S1470-2045(20)30541-6","article-title":"Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial","volume":"21","author":"Powles","year":"2020","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.tranon.2025.102652_bib0005","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJMoa1613683","article-title":"Pembrolizumab as second-line therapy for advanced urothelial carcinoma","volume":"376","author":"Bellmunt","year":"2017","journal-title":"N Engl. J. Med"},{"key":"10.1016\/j.tranon.2025.102652_bib0006","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fimmu.2024.1481296","article-title":"Bladder cancer immune-related markers: diagnosis, surveillance, and prognosis","volume":"15","author":"Yang","year":"2024","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.tranon.2025.102652_bib0007","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41585-023-00773-8","article-title":"Urine biomarkers in bladder cancer \u2014 Current status and future perspectives","volume":"20","author":"Maas","year":"2023","journal-title":"Nat. Rev. Urol"},{"key":"10.1016\/j.tranon.2025.102652_bib0008","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221108690","article-title":"Gender dimorphism in survival of patients with lymph node metastasis of bladder cancer","volume":"14","author":"Guo","year":"2022","journal-title":"Ther. Adv. Med. Oncol"},{"issue":"1","key":"10.1016\/j.tranon.2025.102652_bib0009","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"issue":"5","key":"10.1016\/j.tranon.2025.102652_bib0010","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1600200","article-title":"Fundamentals of cancer metabolism","volume":"2","author":"DeBerardinis","year":"2016","journal-title":"Sci. Adv"},{"issue":"3","key":"10.1016\/j.tranon.2025.102652_bib0011","doi-asserted-by":"crossref","first-page":"98","DOI":"10.62347\/GQZH3508","article-title":"Epigenetic crosstalk between stem cells and tumors: mechanisms and emerging perspectives","volume":"14","author":"Zhou","year":"2025","journal-title":"Am. J. Stem Cells"},{"issue":"10","key":"10.1016\/j.tranon.2025.102652_bib0012","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Mart\u00ednez-Reyes","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.tranon.2025.102652_bib0013","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","article-title":"The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction","volume":"45","author":"Scharping","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.tranon.2025.102652_bib0014","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fimmu.2017.00248","article-title":"Metabolic hallmarks of tumor and immune cells in the tumor microenvironment","volume":"8","author":"Renner","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.tranon.2025.102652_bib0015","article-title":"Loss of cyclin C drives resistance to anti-TIGIT therapy by upregulating CD155-mediated immune evasion","volume":"84","author":"Mao","year":"2025","journal-title":"Drug Resist Updat"},{"issue":"9","key":"10.1016\/j.tranon.2025.102652_bib0016","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1038\/s12276-025-01540-y","article-title":"CircCNOT6L modulates alternative splicing of SLC7A11 via splicing factor SRSF2 to confer ferroptosis resistance and promote metastasis in prostate cancer","volume":"57","author":"Liu","year":"2025","journal-title":"Exp. Mol. Med"},{"issue":"4","key":"10.1016\/j.tranon.2025.102652_bib0017","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1096\/fasebj.10.4.8647346","article-title":"S-adenosylmethionine and methylation","volume":"10","author":"Chiang","year":"1996","journal-title":"Faseb J"},{"issue":"1","key":"10.1016\/j.tranon.2025.102652_bib0018","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/nyas.12956","article-title":"One-carbon metabolism and epigenetics: understanding the specificity","volume":"1363","author":"Mentch","year":"2016","journal-title":"Ann. N Acad. Sci"},{"issue":"3","key":"10.1016\/j.tranon.2025.102652_bib0019","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0031-6997(25)00053-5","article-title":"Pharmacological and biochemical aspects of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase","volume":"34","author":"Ueland","year":"1982","journal-title":"Pharmacol. Rev"},{"issue":"6","key":"10.1016\/j.tranon.2025.102652_bib0020","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ctrv.2012.01.004","article-title":"A review of methionine dependency and the role of methionine restriction in cancer growth control and life-span extension","volume":"38","author":"Cavuoto","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.tranon.2025.102652_bib0021","series-title":"Biology of Bladder Cancer: From Molecular Insights to Clinical Strategies","first-page":"181","article-title":"DNA methylation and chromatin regulators in bladder cancer","author":"Schulz","year":"2024"},{"issue":"1","key":"10.1016\/j.tranon.2025.102652_bib0022","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12672-024-01206-7","article-title":"Exploring prognostic DNA methylation genes in bladder cancer: a comprehensive analysis","volume":"15","author":"Zhang","year":"2024","journal-title":"Discov. Oncol"},{"issue":"1","key":"10.1016\/j.tranon.2025.102652_bib0023","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1186\/s12885-025-13964-w","article-title":"Oncogenic and immunological functions of USP35 in pan-cancer and its potential as a biomarker in kidney clear cell carcinoma","volume":"25","author":"Guo","year":"2025","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2025.102652_bib0024","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10142-025-01642-w","article-title":"Comprehensive multi-omics analysis of nucleotide metabolism: elucidating the role and prognostic significance of UCK2 in bladder cancer","volume":"25","author":"Guo","year":"2025","journal-title":"Funct. Integr. Genom"},{"issue":"1","key":"10.1016\/j.tranon.2025.102652_bib0025","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41467-024-55068-2","article-title":"Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancer","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun"},{"issue":"2","key":"10.1016\/j.tranon.2025.102652_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.70011","article-title":"iMLGAM: integrated Machine Learning and genetic Algorithm-driven multiomics analysis for pan-cancer immunotherapy response prediction","volume":"4","author":"Ye","year":"2025","journal-title":"Imeta"},{"key":"10.1016\/j.tranon.2025.102652_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.654344","article-title":"Functional and pathological roles of AHCY","volume":"9","author":"Viz\u00e1n","year":"2021","journal-title":"Front Cell Dev. Biol"},{"issue":"1","key":"10.1016\/j.tranon.2025.102652_bib0028","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32356-8","article-title":"Knock-down of AHCY and depletion of adenosine induces DNA damage and cell cycle arrest","volume":"8","author":"Belu\u017ei\u0107","year":"2018","journal-title":"Sci. Rep"},{"issue":"7","key":"10.1016\/j.tranon.2025.102652_bib0029","first-page":"2127","article-title":"Inhibition of S-adenosylhomocysteine hydrolase decreases cell mobility and cell proliferation through cell cycle arrest","volume":"5","author":"Park","year":"2015","journal-title":"Am. J. Cancer Res"},{"issue":"1","key":"10.1016\/j.tranon.2025.102652_bib0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2012.06.001","article-title":"Metabolic regulation of epigenetics","volume":"16","author":"Lu","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.tranon.2025.102652_bib0031","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.104138.3","article-title":"Aurora kinase A promotes trained immunity via regulation of endogenous S-adenosylmethionine metabolism","volume":"14","author":"Li","year":"2025","journal-title":"Elife"},{"issue":"10","key":"10.1016\/j.tranon.2025.102652_bib0032","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00109-005-0679-8","article-title":"Intracellular S-adenosylhomocysteine increased levels are associated with DNA hypomethylation in HUVEC","volume":"83","author":"Castro","year":"2005","journal-title":"J. Mol. Med. (Berl)"},{"issue":"2","key":"10.1016\/j.tranon.2025.102652_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2020.01.006","article-title":"Methionine metabolism shapes T helper cell responses through regulation of epigenetic reprogramming","volume":"31","author":"Roy","year":"2020","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.tranon.2025.102652_bib0034","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/s41467-021-21804-1","article-title":"Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma","volume":"12","author":"Hung","year":"2021","journal-title":"Nat. Commun"},{"issue":"2","key":"10.1016\/j.tranon.2025.102652_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2020.01.006","article-title":"Methionine metabolism shapes T helper cell responses through regulation of epigenetic reprogramming","volume":"31","author":"Roy","year":"2020","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.tranon.2025.102652_bib0036","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1038\/s41467-019-12159-9","article-title":"DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load","volume":"10","author":"Jung","year":"2019","journal-title":"Nat. Commun"},{"issue":"7655","key":"10.1016\/j.tranon.2025.102652_bib0037","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nature22367","article-title":"Chromatin states define tumour-specific T cell dysfunction and reprogramming","volume":"545","author":"Philip","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.tranon.2025.102652_bib0038","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bbrc.2013.07.128","article-title":"DZNep, inhibitor of S-adenosylhomocysteine hydrolase, down-regulates expression of SETDB1 H3K9me3 HMTase in human lung cancer cells","volume":"438","author":"Lee","year":"2013","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.tranon.2025.102652_bib0039","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/bs.acr.2021.03.007","article-title":"DNA methylation inhibitors: retrospective and perspective view","volume":"152","author":"Uddin","year":"2021","journal-title":"Adv. Cancer Res"},{"issue":"1","key":"10.1016\/j.tranon.2025.102652_bib0040","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1080\/14756366.2017.1370584","article-title":"Characterization of human S-adenosyl-homocysteine hydrolase in vitro and identification of its potential inhibitors","volume":"32","author":"Hao","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem"},{"key":"10.1016\/j.tranon.2025.102652_bib0041","article-title":"MAT2a and AHCY inhibition disrupts antioxidant metabolism and reduces glioblastoma cell survival","author":"Rowland","year":"2024","journal-title":"BioRxiv"},{"issue":"8","key":"10.1016\/j.tranon.2025.102652_bib0042","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084159","article-title":"PET Molecular imaging: a holistic review of current practice and emerging perspectives for diagnosis, therapeutic evaluation and prognosis in clinical oncology","volume":"22","author":"Duclos","year":"2021","journal-title":"Int. J. Mol. Sci"},{"issue":"7","key":"10.1016\/j.tranon.2025.102652_bib0043","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41568-023-00576-4","article-title":"Advances in PET imaging of cancer","volume":"23","author":"Schwenck","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2025.102652_bib0044","article-title":"Regulation of SLC7A11 as an unconventional checkpoint in tumorigenesis through ferroptosis","volume":"12","author":"Su","year":"2025","journal-title":"Genes Dis"},{"issue":"1","key":"10.1016\/j.tranon.2025.102652_bib0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41420-023-01517-8","article-title":"Ferroptosis and the bidirectional regulatory factor p53","volume":"9","author":"Xu","year":"2023","journal-title":"Cell Death Discov"},{"issue":"2","key":"10.1016\/j.tranon.2025.102652_bib0046","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jhep.2023.03.016","article-title":"ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis","volume":"79","author":"He","year":"2023","journal-title":"J. Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.tranon.2025.102652_bib0047","first-page":"S73","article-title":"S-adenosylmethionine in cell growth, apoptosis and liver cancer","volume":"23","author":"Lu","year":"2008","journal-title":"J. Gastroenterol. Hepatol"},{"issue":"2","key":"10.1016\/j.tranon.2025.102652_bib0048","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/15548627.2021.1924038","article-title":"AHCYL1 senses SAH to inhibit autophagy through interaction with PIK3C3 in an MTORC1-independent manner","volume":"18","author":"Huang","year":"2022","journal-title":"Autophagy"},{"issue":"7769","key":"10.1016\/j.tranon.2025.102652_bib0049","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41586-019-1437-3","article-title":"Dietary methionine influences therapy in mouse cancer models and alters human metabolism","volume":"572","author":"Gao","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.tranon.2025.102652_bib0050","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41419-024-06584-y","article-title":"Metabolism-regulated ferroptosis in cancer progression and therapy","volume":"15","author":"Ye","year":"2024","journal-title":"Cell Death Dis"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325003833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325003833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:55:46Z","timestamp":1781178946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325003833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":50,"alternative-id":["S1936523325003833"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102652","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-omics characterization identifies AHCY as a prognostic biomarker driving immunometabolic reprogramming in bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102652"}}